NewsBenzingaARS Pharmaceuticalsの第3四半期EPSは予想の$(0.31)に対し$(0.36)、売上高は3,771万ドルで予想の4,199万2,000ドルを下回った。 ARS Pharmaceuticalsの第3四半期EPSは予想の$(0.31)に対し$(0.36)、売上高は3,771万ドルで予想の4,199万2,000ドルを下回った。 Benzinga 2026.11.05 21:01 (GMT+0) Open on Benzinga Other news Ramp in Talks to Raise at Least $1 Billion at Valuation of Up to $75 Billion How Everyday Investors Are Playing the Nvidia Drama Curve: Fee Conversion Contract Loses $38.2K in Attack, Disabled With Replacement Planned Alvotech (ALVO) Presents at UBS Global Biopharma Conference 2026 Transcript Nvidia Tops Sales Forecast After Huang's Resignation Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares
Bill Gates Has Earned $2.6 Billion in Dividends From a Landfill Stock the EPA Keeps Citing for Methane Leaks, and a Filing Shows He Just Bought 3.7M More Shares